← All stocks

BIO vs SNN

Bio-Rad Laboratories Inc. Class A Common Stock vs Smith & Nephew SNATS Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BIO
Bio-Rad Laboratories Inc. Class A Common Stock
Healthcare
376.41
10.07B
SNN
Smith & Nephew SNATS Inc. Common Stock
Healthcare
27.56
11.53B
ACCE scores
BIO
SNN
Composite score
Out of 100
59
50
Growth
35
40
Value
41
75
Quality
62
67
Momentum
97
17
Valuation
BIO
SNN
Price
376.41
27.56
Market cap
10.07B
11.53B
Trailing P/E
45.85
18.75
Forward P/E
40.98
11.19
EV / EBITDA
17.18
9.23
Dividend yield
0.0%
2.9%
Profitability
BIO
SNN
ROE
3.1%
11.8%
Net margin
8.6%
10.1%
Debt / equity
0.16
0.59
Free cash flow
374.60M
852.00M
Growth
BIO
SNN
Revenue growth (YoY)
-0.1%
4.6%
Earnings growth (YoY)
18.7%
5.7%
Analyst target
329.00
32.89
See full analysis